Ondansetron Ratiopharm

Ondansetron, the active ingredient in Ondansetron Ratiopharm, is a 5-HT3 receptor antagonist presented as a tablet for oral use. It helps prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery in adults and children. GNH USA supplies Ondansetron Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ondansetron Ratiopharm is used to manage nausea and vomiting by targeting the serotonergic pathway.

- Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting: helps control symptoms during and after radiotherapy. - Post‑operative nausea and vomiting: decreases the incidence of nausea and vomiting after surgical procedures. - Pregnancy‑related nausea (off‑label): may be considered when benefits outweigh risks, under specialist specialist . - Hyper‑catalytic